期刊文献+

异烟肼缓释植入剂的制备和体外释放 被引量:2

Preparation of isoniazid sustained release implant and the release behavior in vitro
原文传递
导出
摘要 目的:探讨异烟肼缓释植入剂的制备工艺和体外释放特性。方法:选用最佳处方,采用压模成型法制备。建立异烟肼植入剂的释放度检测方法,用不同方程拟合不同时间段异烟肼植入剂的释放曲线。结果:25%的载药量,以丙酮做溶剂制备的植入剂在80d后,累积释药量达85%以上;最初10d的释放量较大,之后变平稳,Mt/M∞t的相关性良好(r=0.9924,P=0.000)。结论:选用最佳处方制备的植入剂具有良好的缓释效果。 OBJECHVE To prepare isoniazid (INH) implant and evaluate the release behavior in vitro. METHODS Compression molding forming was used to prepare the INH implant, of which prescription was screened; A method of determining INH release from the preparation in vitro was established, and different equations were used to fit the release profiles of INH implant. RESULTS The accumulative release percentage of INH from the implant within 80 d were more than 85%, which was prepared by 25% drug loading and acetone. The release quantities of the implant were greater in first 10 days, and then kept steady. The correlation of accumulative release quantities(Mt/M∞ ) in vitro with release time(t) was good(r = 0. 992 4,P = 0. (100). CONCLUSION The implant prepared by the best prescription have a better sustained release behavior.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2009年第4期299-302,共4页 Chinese Journal of Hospital Pharmacy
关键词 异烟肼植入剂 制备 体外释放 isoniazid implant preparation in vitro release
  • 相关文献

参考文献7

  • 1吴在德,吴肇汉.外科学[M].6版.北京:人民卫生出版社,2003:52
  • 2B Jeong, YK Choi, YH Bae, et al. New biodegradable polymers for injectable drug delivery systems[J]. Journal of Controlled Release, 62, ( 1999 ) : 109-114.
  • 3史美甫,郭涛,李明.精编药物临床用药必备[M].北京:中国科学技术出版社,2003:873.
  • 4DJA Netz, P Sepulveda, VC Pandolfelli,et al. Potential use of gelcasting hydroxyapatite porous ceramic as an implantable drug delivery system[J]. International Journal of Pharmaecutiecs, 213, (2001) : 117-125.
  • 5Noriyuki Kunou, Yuichiro Ogura, Mototane Hashizoe,et al. Controlled intraocular delivery of gancicolovir with use of bio degradable scleral implant in rabbits[J]. Journal of Controlled Release,37, (1995) : 143 150.
  • 6潘兆芝,洪建文.HPLC法测定卫肺特片中利福平、异烟肼和吡嗪酰胺的含量[J].广东药学院学报,1998,14(3):203-204. 被引量:2
  • 7.中国药典二部[S].,2005年版.68.

共引文献269

同被引文献18

  • 1周刚,徐晓月,张黎莉,王继峰,李思思,王高峰.复方异烟肼胶囊中利福平在犬体内的生物利用度[J].中国医院药学杂志,2006,26(2):160-162. 被引量:7
  • 2杨劼,旋志刚,李涛.异烟肼双层栓的研制及药动学[J].河北医药,2006,28(3):226-227. 被引量:9
  • 3WUZD,WUZH.Surgery(外科学).6thed[M].Bering:Peo-pie’sMedicalPublishingHouse,2003:898-908.
  • 4JEONG B, CHOI Y K, BAE Y H, et al. New biodegradable pol- ymers for injectable drug delivery systems [ J ]. J Controlled Re- lease,1999,62(1-2) :109-114.
  • 5NETZ D J A, SEPULVEDA P, PANDOLFELLI V C, et al. Po- tential use of gelcasting hydroxyapatite porous ceramic as an im- plantable drug delivery system[J], lnt J Pharm, 2001,213( 1- 2) :117-125.
  • 6NORIYUKI K, YUICHIRO O, MOTOTANE H, et al. Controlled intraocular delivery of gancicolovir with use of biodegradable scleral implant in rabbits [ J ]. J Controlled Release, 1995,37 ( 1 - 2 ) : 143-150.
  • 7PAN Z Z, HONG J W. Determination of rifampicin,isoniazid and pyrazinamide in WeiFeiTe tablets by HPLC [ J ]. 广东药学院学报,1998,14(3):203-204.
  • 8∞.P(2005)Vol Ⅱ(中国药典2010年版.二部)[S].2005:41.
  • 9UNSALAN S, SANCAR M, BEKCE B, et al. Therapeutic moni- toring of isoniazid, pyrazinamide and rifampicin in tuberculosis patients using LC [ J ]. Chromatographia, 2005,61 : 595-598.
  • 10CHENXQ,JINYY,TANGG.NewMedica(新编药物学)16th ed) [ M ]. Beijing: People' s Medical Publishing House, 2007:115-116.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部